Navigation Links
Schedules Revised for Flu, Meningitis Vaccines
Date:1/11/2008

Goal is to make it easier for parents to protect their children, CDC says

FRIDAY, Jan. 11 (HealthDay News) -- Expanded use of the FluMist vaccine for children and revised meningococcal vaccination guidelines for teens are part of new immunization recommendations released Friday.

The 2008 Childhood and Adolescent Immunization Schedules were released jointly by the U.S. Centers for Disease Control and Prevention, the American Academy of Pediatrics, and the American Academy of Family Physicians.

"Although we can now protect more children against more vaccine-preventable diseases than ever before, the immunization schedules can be confusing for parents and physicians," Dr. Anne Schuchat, director of the CDC's National Center for Immunization and Respiratory Diseases, said in a prepared statement. "The updates to this year's schedule help clarify our vaccination recommendations and, therefore, should make it easier for parents to protect their children against potentially serious diseases."

The childhood schedule changes to expand the recommendation for the nasal spray flu vaccine, FluMist, to now include children from 2 to 4 years of age without a history of asthma or wheezing. The vaccine, which contains a weakened form of the live virus and is sprayed in the nose, had previously been limited to healthy children 5 years of age and older and healthy adults up to age 50.

"We know that vaccinating children protects them against flu," Schuchat said. "This recommendation gives parents another choice when vaccinating their children."

The updated immunization schedule also includes vaccination against meningococcal disease, or meningitis. The Meningococcal Conjugate Vaccine (MCV4) is now recommended for children 11 to 12 years of age and teens 13 to 18 years of age who haven't been previously vaccinated and other people at heightened risk of meningococcal disease, including college freshmen living in dorms, as well as military recruits, the statement said.

Schuchat said the meningococcal disease recommendation modifies and simplifies the previous recommendation for routine vaccination with MCV4 of children 11 to 12 years of age, teens before starting high school (approximately 15 years of age), and other people at increased risk.

"Our goal is routine vaccination of all children beginning at age 11 years. College freshmen living in dormitories are at increased risk of meningococcal disease and should be vaccinated with MCV4 before college entry, if not previously," Schuchat said.

The new schedule also clarifies and updates recommendations for use of pneumococcal vaccine, which protects against pneumonia. Healthy children 24 months through 59 months of age not completely vaccinated should receive one dose of pneumococcal conjugate vaccine (PCV4). Children 2 year of age and older with underlying medical conditions should receive pneumococcal polysaccharide vaccine (PPV), the statement said.

More information

For more on vaccine-preventable childhood diseases, visit the CDC.



-- HealthDay staff



SOURCE: U.S. Centers for Disease Control and Prevention, Atlanta, news release, Jan. 11, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Echo Healthcare Reschedules Stockholder Vote on Proposed Merger With XLNT Veterinary Care to December 21, 2007
2. Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto
3. The Female Health Company Schedules Fiscal Year End Conference Call for Monday, November 26, 2007
4. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
5. GNC Schedules Conference Call and Webcast to Report Third Quarter 2007 Financial Results
6. Thoratec Schedules Third Quarter Conference Call, Webcast
7. MSA Schedules Third Quarter Earnings Webcast
8. WuXi PharmaTech Schedules 2007 Third Quarter Earnings Release on Monday, November 12, 2007
9. Cardiac Science Corporation Schedules Third Quarter Earnings Release and Announces Conference Call
10. Cepheid Schedules Teleconference and Webcast for Third Quarter 2007 Results
11. AMICAS Schedules Third Quarter Earnings Call
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Schedules Revised for Flu, Meningitis Vaccines
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
Breaking Medicine Technology: